Famciclovir Tablet, Film Coated
FDA Label NDC 55289-168

35 label sections · Submitted to the FDA by Pd-rx Pharmaceuticals, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pd-rx Pharmaceuticals, Inc. for the product Famciclovir (NDC 55289-168). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 immunocompetent adult patients, 1.2 hiv-infected adult patients, 2 dosage and administration, 2.1 dosing recommendation in immunocompetent adult patients, 2.2 dosing recommendation in hiv-infected adult patients, 2.3 dosing recommendation in patients with renal impairment, 3 dosage forms and strengths, 4 contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.